23 May 2013
Keywords: millennium, start, velcade, ph, iii, study, companies
Article | 17 January 2005
US companies Millennium Pharmaceuticals and Johnson & Johnson Pharmaceutical R&D have initiated VISTA (Velcade as Initial Standard
Therapy in multiple ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 January 2005
© 2013 thepharmaletter.com